ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Milano, Lombardia

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Glioma
Brain Cancer
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Milano, Lombardia, ITA:

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (FIGHT-209)

This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblastoma (GBM) or other recurrent glioma...

Active, not recruiting
Glioblastoma
Adult-type Diffuse Gliomas
Drug: Pemigatinib

Phase 2

Incyte
Incyte

Milano, Italy and 80 other locations

The PhAST Trial is an adaptive first-in-human clinical trial of the acetylglucosaminyltransferase V inhibitor PhOx430 in patients with advanced solid...

Enrolling
Glioblastoma Multiforme
Metastatic Cancer
Drug: PhOx430

Phase 1

Phost'In Therapeutics

Milano, Italy and 1 other location

dd-TMZ "one week on, one week off" in patients affected by recurrent GBM IDH wild-type and recurrent IDH mutant (WHO grade 2-4) gliomas.The ...

Not yet enrolling
Glioma, Malignant
Drug: Niraparib
Drug: Temodal

Phase 1, Phase 2

Armando Santoro, MD

Rozzano, Mi, Italy

with a lentiviral vector driving myeloid specific interferon-alpha2 expression, which will be administered to up to 27 patients affected by GBM...

Enrolling
Glioblastoma Multiforme
Drug: Temferon

Phase 1, Phase 2

Genenta Science

Milan, Italy and 2 other locations

This is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study. Patients with GBM after failure of standard firs...

Active, not recruiting
Glioblastoma Multiforme, Adult
Drug: Berubicin
Drug: Lomustine

Phase 2

CNS Pharmaceuticals
CNS Pharmaceuticals

Milan, Italy and 47 other locations

The proposed Phase IIB/III randomized, double-blind, placebo-controlled trial in subjects with newly diagnosed primary glioblastoma multifor...

Active, not recruiting
Glioblastoma Multiforme
Primary Glioblastoma
Drug: TMZ
Drug: LAM561

Phase 2, Phase 3

Laminar Pharma

Milan, Italy and 21 other locations

To assess:* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification...

Enrolling
Glioblastoma Multiforme
Brain Tumor
Drug: APL-101 Oral Capsules

Phase 2

Apollomics

Milan, Italy and 90 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems